Renoprotection in diabetes: genetic and non-genetic risk factors and treatment

被引:126
作者
Parving, HH [1 ]
机构
[1] Steno Diabet Ctr, DK-2820 Gentofte, Denmark
关键词
Type I and Type II diabetes; microalbuminuria; diabetic nephropathy; antihypertensive treatment; angiotensin converting inhibition; renal progression promoters; insertion/deletion polymorphism of angiotensin converting enzyme gene; end stage renal failure; glycaemic control;
D O I
10.1007/s001250050983
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:745 / 759
页数:15
相关论文
共 190 条
[1]  
ABOUNA GM, 1983, LANCET, V2, P1274
[2]   Effective postponement of diabetic nephropathy with enalapril in normotensive type 2 diabetic patients with microalbuminuria [J].
Ahmad, J ;
Siddiqui, MA ;
Ahmad, H .
DIABETES CARE, 1997, 20 (10) :1576-1581
[3]  
Alaveras A, 1997, DIABETOLOGIA, V40, P64
[4]  
Alaveras AEG, 1997, NEPHROL DIAL TRANSPL, V12, P71
[5]  
ANDERSEN AR, 1983, DIABETOLOGIA, V25, P496
[6]  
[Anonymous], KIDNEY
[7]  
APPERLOO AJ, 1994, KIDNEY INT, V45, pS174
[8]   A short-term antihypertensive treatment-induced fall in glomerular filtration rate predicts long-term stability of renal function [J].
Apperloo, AJ ;
deZeeuw, D ;
deJong, PE .
KIDNEY INTERNATIONAL, 1997, 51 (03) :793-797
[9]   Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy [J].
Bakris, GL ;
Copley, JB ;
Vicknair, N ;
Sadler, R ;
Leurgans, S .
KIDNEY INTERNATIONAL, 1996, 50 (05) :1641-1650
[10]   HYPERTENSION AND RENAL DISEASES [J].
BALDWIN, DS ;
NEUGARTEN, J .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1987, 10 (03) :186-191